Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Martin

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2013
A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancerJonathan D Schoenfeld, Danielle N Margalit, Julie L Kasperzyk, et al.
The Journal of Urology|February 15, 2015
Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate CancerKathryn T Dinh, Brandon A Mahal, David R Ziehr, et al.
Advances in Radiation Oncology|July 18, 2022
Magnetic Resonance-Guided Prostate Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation: Results of a Prospective Phase 1 Trial and Supplemental CohortJonathan E Leeman, Daniel N Cagney, Raymond H Mak, et al.
Ear and Hearing|January 24, 2022
Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric AssessmentsShirin Ardeshirrouhanifard, Sophie D Fossa, Robert Huddart, et al.
BJU International|April 8, 2015
Risk of prostate cancer mortality in men with a history of prior cancerKathryn T Dinh, Brandon A Mahal, David R Ziehr, et al.
Brachytherapy|June 2, 2014
Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term resultsBrandon A Mahal, David R Ziehr, Andrew S Hyatt, et al.
Journal of the National Cancer Institute|February 3, 2025
Factors associated with longitudinal progression of the cumulative burden of morbidity and overall mortality after cisplatin-based chemotherapy for testicular cancerSarah L Kerns, Paul C Dinh, Patrick O Monahan, et al.
Journal of the National Cancer Institute|November 15, 2023
Impact of pain and adverse health outcomes on long-term US testicular cancer survivorsPaul C Dinh, Patrick O Monahan, Sophie D Fosså, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2023
Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based ChemotherapyVictoria A Sanchez, Megan M Shuey, Paul C Dinh, et al.
Clinical Genitourinary Cancer|May 28, 2014
Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancerBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2013
A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancerJonathan D Schoenfeld, Danielle N Margalit, Julie L Kasperzyk, et al.
The Journal of Urology|February 15, 2015
Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate CancerKathryn T Dinh, Brandon A Mahal, David R Ziehr, et al.
Advances in Radiation Oncology|July 18, 2022
Magnetic Resonance-Guided Prostate Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation: Results of a Prospective Phase 1 Trial and Supplemental CohortJonathan E Leeman, Daniel N Cagney, Raymond H Mak, et al.
Ear and Hearing|January 24, 2022
Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric AssessmentsShirin Ardeshirrouhanifard, Sophie D Fossa, Robert Huddart, et al.
BJU International|April 8, 2015
Risk of prostate cancer mortality in men with a history of prior cancerKathryn T Dinh, Brandon A Mahal, David R Ziehr, et al.
Brachytherapy|June 2, 2014
Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term resultsBrandon A Mahal, David R Ziehr, Andrew S Hyatt, et al.
Journal of the National Cancer Institute|February 3, 2025
Factors associated with longitudinal progression of the cumulative burden of morbidity and overall mortality after cisplatin-based chemotherapy for testicular cancerSarah L Kerns, Paul C Dinh, Patrick O Monahan, et al.
Journal of the National Cancer Institute|November 15, 2023
Impact of pain and adverse health outcomes on long-term US testicular cancer survivorsPaul C Dinh, Patrick O Monahan, Sophie D Fosså, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2023
Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based ChemotherapyVictoria A Sanchez, Megan M Shuey, Paul C Dinh, et al.
Clinical Genitourinary Cancer|May 28, 2014
Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancerBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.
Pageof 13